The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study.
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001519:Behavior / Q000187:drug effects; D002220:Carbamazepine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002540:Cerebral Cortex / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003201:Computers; D004341:Drug Evaluation; D004569:Electroencephalography; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy* / Q000503:physiopathology; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D010919:Placebos; D013686:Telemetry
D010919:Placebos; D002220:Carbamazepine; D010672:Phenytoin; D010634:Phenobarbital